Drug Profile
Research programme: monoclonal antibodies-hyaluronic acid complex - Alchemia
Alternative Names: HA-monoclonal antibodiesLatest Information Update: 28 Dec 2019
Price :
$50
*
At a glance
- Originator Alchemia
- Class Monoclonal antibodies
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Dec 2019 No recent reports of development identified for preclinical development in Cancer in Australia (Parenteral)
- 25 Nov 2015 Preclinical trials in Cancer in Australia (Parenteral)
- 07 May 2010 Early research in Cancer in Australia (Parenteral)